Methods: JNJ-26481585 was administered orally, once daily (QD) in 3-weekly cycles to advanced cancer patients (pts) using a 2-stage accelerated titration design. Due to poor …
[引用][C]1237 POSTER WIN55, 212-2 as a Potential Treatment for Estrogen-receptor Negative Breast Cancer
K Tran, M Nimick, S Taurin, B Yadav… - European Journal of …, 2011 - Pergamon